The expression and clinical significance of ribophorin II (RPN2) in human breast cancer (Q34472128)

2 August 2017

title

The expression and clinical significance of ribophorin II (RPN2) in human breast cancer (English)

1 reference

2 August 2017

13

Takahiro Ochiya

1 reference

2 August 2017

2

Hitoshi Tsuda

1 reference

2 August 2017

10

Takayuki Kinoshita

1 reference

2 August 2017

7

Sadako Akashi-Tanaka

1 reference

2 August 2017

12

Yasuhiro Fujiwara

1 reference

2 August 2017

6

Kenji Tamura

1 reference

2 August 2017

Makiko Ono

1

1 reference

2 August 2017

Takayuki Kobayashi

3

1 reference

2 August 2017

Fumitaka Takeshita

4

1 reference

2 August 2017

Ryou-U Takahashi

5

1 reference

2 August 2017

Tomoyuki Moriya

8

1 reference

2 August 2017

Tamio Yamasaki

9

1 reference

2 August 2017

Junji Yamamoto

11

1 reference

2 August 2017

publication date

15 April 2015

1 reference

2 August 2017

published in

Pathology International

1 reference

2 August 2017

volume

65

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

301-308

1 reference

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

2 August 2017

cites work

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

21 January 2018

1 reference

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

21 January 2018

1 reference

RPN2 gene confers docetaxel resistance in breast cancer

21 January 2018

1 reference

Cancer stem cells in breast cancer

21 January 2018

1 reference

Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β.

21 January 2018

1 reference

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis

21 January 2018

1 reference

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

21 January 2018

1 reference

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

21 January 2018

1 reference

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

21 January 2018

1 reference

Mutant p53 drives invasion by promoting integrin recycling

21 January 2018

1 reference

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

21 January 2018

1 reference

Genetic basis for p53 overexpression in human breast cancer

21 January 2018

1 reference

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PIN.12297

1 reference

2 August 2017

1 reference